Editorial: BCG in cancer.
出版信息
Br Med J. 1976 Jun 19;1(6024):1487.
Abstract
摘要
相似文献
1
Editorial: BCG in cancer.社论：卡介苗与癌症
Br Med J. 1976 Jun 19;1(6024):1487.
2
[Cancer immunotherapy with BCG cell-wall skeleton (author's transl)].卡介苗细胞壁骨架的癌症免疫疗法（作者译）
Tanpakushitsu Kakusan Koso. 1978 May;23(6):625-40.
3
The methanol extract residue (MER) of bacillus calmette-guerin in cancer immunotherapy.卡介苗的甲醇提取物残渣在癌症免疫治疗中的应用
Nurs Clin North Am. 1978 Jun;13(2):369-80.
4
Immunotherapy of cancer in man.
Am Sci. 1976 Jul-Aug;64(4):418-23.
5
A technique for intensifying BCG sensitivity.一种增强卡介苗敏感性的技术。
J Med. 1975;6(3-4):213-6.
6
[Cancer immunotherapy and its fundamental basis (author's transl)].[癌症免疫疗法及其基本原理（作者译）]
Nihon Hifuka Gakkai Zasshi. 1976 Sep 10;86(10):584-91.
7
Experimental and clinical trials with BCG immunotherapy.卡介苗免疫疗法的实验和临床试验。
Johns Hopkins Med J Suppl. 1974;3:103-20.
8
BCG-RIVM: a new BCG preparation for intravesical immunotherapy of superficial bladder cancer.BCG-RIVM：一种用于浅表性膀胱癌膀胱内免疫治疗的新型卡介苗制剂。
Chemioterapia. 1987 Jun;6(2 Suppl):713-6.
9
Conference on the use of BCG in therapy of cancer. Summary remarks.卡介苗在癌症治疗中的应用会议。总结发言。
Natl Cancer Inst Monogr. 1973 Dec;39:269-72.
本文引用的文献
1
Migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity.循环中迁移抑制因子和干扰素与小鼠迟发型超敏反应。
Infect Immun. 1973 Jan;7(1):68-75. doi: 10.1128/iai.7.1.68-75.1973.
2
Enhanced resistance of mice to infection with Pasteurella pestis following vaccination with fractions of phenol-killed tubercle bacilli.
Nature. 1960 Jun 25;186:1060-1. doi: 10.1038/1861060a0.
3
Immunity to methylcholanthrene-induced sarcomas.对甲基胆蒽诱导肉瘤的免疫性。
J Natl Cancer Inst. 1957 Jun;18(6):769-78.
4
Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin.甲基胆蒽诱发的原种系小鼠肿瘤的抗原特性。
Cancer Res. 1953 Dec;13(12):835-7.
5
Approaches to the immunological treatment of cancer in man.人类癌症免疫治疗的方法。
Br Med J. 1969 Oct 4;4(5674):7-10. doi: 10.1136/bmj.4.5674.7.
6
Response of syngeneic murine lymphomata to immunotherapy in relation to the antigenicity of the tumour.同基因小鼠淋巴瘤对免疫疗法的反应与肿瘤抗原性的关系。
Br J Cancer. 1972 Jun;26(3):174-82. doi: 10.1038/bjc.1972.24.
7
BCG immunotherapy of pulmonary growths from intravenously transferred rat tumour cells.经静脉注射转移大鼠肿瘤细胞所致肺部肿瘤的卡介苗免疫疗法
Br J Cancer. 1973 Jan;27(1):48-54. doi: 10.1038/bjc.1973.6.
8
Mechanism of immunologically specific killing of tumour cells by macrophages.巨噬细胞对肿瘤细胞进行免疫特异性杀伤的机制。
Nature. 1972 Mar 24;236(5343):168-70. doi: 10.1038/236168a0.
9
BCG and cancer (first of two parts).卡介苗与癌症（两部分中的第一部分）
N Engl J Med. 1974 Jun 20;290(25):1413-20. doi: 10.1056/NEJM197406202902506.
10
Macrophage nonimmunologic recognition: target cell factors related to contact inhibition.巨噬细胞的非免疫识别：与接触抑制相关的靶细胞因子。
Science. 1973 May 25;180(4088):868-70. doi: 10.1126/science.180.4088.868.
Zotero 插件